These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 26092642)

  • 1. Cellular and molecular mechanisms of chikungunya pathogenesis.
    Lum FM; Ng LF
    Antiviral Res; 2015 Aug; 120():165-74. PubMed ID: 26092642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chikungunya virus pathogenesis: From bedside to bench.
    Couderc T; Lecuit M
    Antiviral Res; 2015 Sep; 121():120-31. PubMed ID: 26159730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chikungunya virus pathogenesis and immunity.
    Gasque P; Couderc T; Lecuit M; Roques P; Ng LF
    Vector Borne Zoonotic Dis; 2015 Apr; 15(4):241-9. PubMed ID: 25897810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chikungunya virus: host pathogen interaction.
    Singh SK; Unni SK
    Rev Med Virol; 2011 Mar; 21(2):78-88. PubMed ID: 21412934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology.
    Teo TH; Her Z; Tan JJ; Lum FM; Lee WW; Chan YH; Ong RY; Kam YW; Leparc-Goffart I; Gallian P; Rénia L; de Lamballerie X; Ng LF
    J Virol; 2015 Aug; 89(15):7955-69. PubMed ID: 25995257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathology of Chikungunya Virus Infection: Lessons Learned from Patients and Animal Models.
    Ng LFP
    Annu Rev Virol; 2017 Sep; 4(1):413-427. PubMed ID: 28637387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
    Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal Models of Chikungunya Virus Infection and Disease.
    Haese NN; Broeckel RM; Hawman DW; Heise MT; Morrison TE; Streblow DN
    J Infect Dis; 2016 Dec; 214(suppl 5):S482-S487. PubMed ID: 27920178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.
    Amdekar S; Parashar D; Alagarasu K
    Viral Immunol; 2017 Dec; 30(10):691-702. PubMed ID: 28910194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.
    Fox JM; Diamond MS
    J Immunol; 2016 Dec; 197(11):4210-4218. PubMed ID: 27864552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chikungunya virus-vector interactions.
    Coffey LL; Failloux AB; Weaver SC
    Viruses; 2014 Nov; 6(11):4628-63. PubMed ID: 25421891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
    Cook LE; Locke MC; Young AR; Monte K; Hedberg ML; Shimak RM; Sheehan KCF; Veis DJ; Diamond MS; Lenschow DJ
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and Molecular Immune Response to Chikungunya Virus Infection.
    Tanabe ISB; Tanabe ELL; Santos EC; Martins WV; Araújo IMTC; Cavalcante MCA; Lima ARV; Câmara NOS; Anderson L; Yunusov D; Bassi ÊJ
    Front Cell Infect Microbiol; 2018; 8():345. PubMed ID: 30364124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
    Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
    J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review.
    Lo Presti A; Cella E; Angeletti S; Ciccozzi M
    Infect Genet Evol; 2016 Jul; 41():270-278. PubMed ID: 27085290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathogenesis of Chikungunya infection: astrogliosis and innate immune activation.
    Inglis FM; Lee KM; Chiu KB; Purcell OM; Didier PJ; Russell-Lodrigue K; Weaver SC; Roy CJ; MacLean AG
    J Neurovirol; 2016 Apr; 22(2):140-8. PubMed ID: 26419894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human keratinocytes restrict chikungunya virus replication at a post-fusion step.
    Bernard E; Hamel R; Neyret A; Ekchariyawat P; Molès JP; Simmons G; Chazal N; Desprès P; Missé D; Briant L
    Virology; 2015 Feb; 476():1-10. PubMed ID: 25496825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chikungunya: Evolutionary history and recent epidemic spread.
    Weaver SC; Forrester NL
    Antiviral Res; 2015 Aug; 120():32-9. PubMed ID: 25979669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
    Her Z; Teng TS; Tan JJ; Teo TH; Kam YW; Lum FM; Lee WW; Gabriel C; Melchiotti R; Andiappan AK; Lulla V; Lulla A; Win MK; Chow A; Biswas SK; Leo YS; Lecuit M; Merits A; Rénia L; Ng LF
    EMBO Mol Med; 2015 Jan; 7(1):24-41. PubMed ID: 25452586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk.
    Rougeron V; Sam IC; Caron M; Nkoghe D; Leroy E; Roques P
    J Clin Virol; 2015 Mar; 64():144-52. PubMed ID: 25453326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.